Difference between revisions of "Pulseless ventricular tachycardia epidemiology and demographics"

Jump to: navigation, search
(Overview)
 
Line 7: Line 7:
  
 
==Epidemiology and Demographics==
 
==Epidemiology and Demographics==
===Incidence===
+
For more see [[Ventricular tachycardia epidemiology and demographics|Epidemiology and Demographics]] of ventricular tachycardia.
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
 
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
 
 
===Prevalence===
 
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
 
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 
 
 
===Case-fatality rate/Mortality rate===
 
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
 
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 
 
 
===Age===
 
*Patients of all age groups may develop [disease name].
 
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
 
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
 
*[Chronic disease name] is usually first diagnosed among [age group].
 
*[Acute disease name] commonly affects [age group].
 
 
 
===Race===
 
*There is no racial predilection to [disease name].
 
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
 
*[Disease name] affects men and women equally.
 
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
 
 
===Region===
 
*The majority of [disease name] cases are reported in [geographical region].
 
 
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
 
 
===Developed Countries===
 
 
 
===Developing Countries===
 
  
 
==References==
 
==References==

Latest revision as of 13:30, 1 July 2020

Pulseless ventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulseless ventricular tachycardia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography

Cardiac MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulseless ventricular tachycardia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulseless ventricular tachycardia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulseless ventricular tachycardia epidemiology and demographics

CDC on Pulseless ventricular tachycardia epidemiology and demographics

Pulseless ventricular tachycardia epidemiology and demographics in the news

Blogs on Pulseless ventricular tachycardia epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pulseless ventricular tachycardia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

Overview

Ventricular tachycardia and ventricular fibrillation[1] are the causes of most sudden cardiac deaths and account for about 300,000 deaths per year in the united states alone. This figure is most likely underestimated as it doesn't account for deaths due to unwitnessed dysrhythmias.[2]

Epidemiology and Demographics

For more see Epidemiology and Demographics of ventricular tachycardia.

References

  1. Tang PT, Shenasa M, Boyle NG (December 2017). "Ventricular Arrhythmias and Sudden Cardiac Death". Card Electrophysiol Clin. 9 (4): 693–708. doi:10.1016/j.ccep.2017.08.004. PMID 29173411.
  2. McNally B, Robb R, Mehta M, Vellano K, Valderrama AL, Yoon PW, Sasson C, Crouch A, Perez AB, Merritt R, Kellermann A (July 2011). "Out-of-hospital cardiac arrest surveillance --- Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005--December 31, 2010". MMWR Surveill Summ. 60 (8): 1–19. PMID 21796098.




Linked-in.jpg